Eventide Asset Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-281,569
| Closed | -$3.94M | – | 141 |
|
|
2022
Q2 | $3.94M | Sell |
281,569
-118,431
| -30% | -$1.66M | 0.08% | 126 |
|
|
2022
Q1 | $6.46M | Hold |
400,000
| – | – | 0.1% | 118 |
|
|
2021
Q4 | $8.56M | Hold |
400,000
| – | – | 0.11% | 115 |
|
|
2021
Q3 | $5.88M | Hold |
400,000
| – | – | 0.08% | 133 |
|
|
2021
Q2 | $7.96M | Hold |
400,000
| – | – | 0.11% | 124 |
|
|
2021
Q1 | $12M | Buy |
+400,000
| New | +$12M | 0.18% | 112 |
|